Talk:Gevokizumab

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Gevokizumab.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Copied and pasted from other sources

This article seems to be directly C&Pd from various sources, including company websites and press releases. E.g. http://www.servier.com/content/servier-initiates-phase-2-study-gevokizumab-patients-diabetic-nephropathy and http://www.fiercebiotech.com/r-d/xoma-crushed-as-lead-drug-flunks-a-phiii-challenge

The clue is in the language... "a potent mAb... with unique properties", "In July 2015 the drug suffered a Phase III failure in patients with Behçet's disease uveitis was a bust."

Cloning jedi (talk) 12:02, 11 July 2016 (UTC)[reply]